Get the Stockscreener App
2.00
12.99%
0.23
Pre-market:
2.04
0.04
+2.00%
Tivic Health Systems Inc stock is traded at $2.00, with a volume of 203.54K.
It is up +12.99% in the last 24 hours and down -13.42% over the past month.
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
See More
Previous Close:
$1.77
Open:
$1.85
24h Volume:
203.54K
Relative Volume:
3.00
Market Cap:
$3.53M
Revenue:
$957.00K
Net Income/Loss:
$-6.42M
P/E Ratio:
-0.6473
EPS:
-3.0899
Net Cash Flow:
$-6.13M
1W Performance:
+13.64%
1M Performance:
-13.42%
6M Performance:
-51.81%
1Y Performance:
-55.54%
1-Day Range:
$1.85
$2.2274
1-Week Range:
$1.72
$2.2274
52-Week Range:
$1.47
$15.64
Tivic Health Systems Inc Stock (TIVC) Company Profile
Name
Tivic Health Systems Inc
Sector
Industry
Phone
(888)276-6888
Address
47685 LAKEVIEW BLVD, FREMONT
Compare TIVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIVC
Tivic Health Systems Inc
|
2.00 | 3.13M | 957.00K | -6.42M | -6.13M | -3.0899 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tivic Health Systems Inc Stock (TIVC) Latest News
Form 8-KCurrent report - ADVFN
Is Tivic Health Systems Inc. stock cheap compared to fundamentalsTrade Risk Report & Target Return Focused Stock Picks - newser.com
What high frequency data says about Tivic Health Systems Inc.New Guidance & Verified Swing Trading Watchlist - newser.com
Tivic Health secures BARDA meeting for entolimod in ARS - MSN
Why Tivic Health Systems Inc. stock is considered a top pick2025 Technical Patterns & Safe Entry Momentum Stock Tips - newser.com
Tivic Health Shares Rise After US Agency Meeting on Entolimod Set - MarketScreener
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Tivic Secures BARDA Meeting for Entolimod(TM) for Acute Radiation Syndrome - ACCESS Newswire
Tivic Health Systems Secures BARDA Meeting for Entolimod - TradingView
[8-K] Tivic Health Systems, Inc. Reports Material Event | TIVC SEC FilingForm 8-K - Stock Titan
Tivic Health (NASDAQ: TIVC) to Present Entolimod ARS Data in BARDA TechWatch Meeting - Stock Titan
Will Tivic Health Systems Inc. stock go up soon2025 Price Momentum & Reliable Volume Spike Trade Alerts - newser.com
Tivic Health’s Earnings Call: Strategic Shift and Challenges - TipRanks
Is OK Play India Limited One of the Top Picks for Growth Investors in YEAREarnings Season Recap & Build Wealth With Strategy - earlytimes.in
Can Tivic Health Systems Inc. stock double in next 5 yearsCPI Data & AI Powered Buy and Sell Recommendations - newser.com
Tivic Health reports finding from clinical optimization trial of ncVNS - MSN
Is Tivic Health Systems Inc. stock trading near support levelsJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Tivic Health Systems Advances Biologics Pipeline - MSN
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q3 2025 Earnings Call Transcript - Insider Monkey
Tivic files patent applications for cancer therapy, nerve stimulation device - MSN
Earnings call transcript: Tivic Health Systems Q3 2025 sees strategic shift - Investing.com Nigeria
Tivic Health Systems Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Tivic Health Systems Q3 2025 sees strategic shift By Investing.com - Investing.com South Africa
Tivic Health Systems Shifts Focus to Biopharma Program - TipRanks
Bioelectronic medicine maker Tivic Health's Q3 net loss widens - MarketScreener
TIVC: Shifted focus to biologics, exited consumer health, and secured funding for Entolimod progress - TradingView
Tivic Reports Third Quarter 2025 Financial Results - ACCESS Newswire
Tivic Health (NASDAQ: TIVC) posts third-quarter cash $3.5M, $3.8M financing - Stock Titan
Why Tivic Health Systems Inc. stock is a must watch in 2025Market Performance Summary & Free Safe Entry Trade Signal Reports - Fundação Cultural do Pará
Tivic Health optimizes nerve stimulation parameters in new study By Investing.com - Investing.com Nigeria
Why Tivic Health Systems Inc. stock is a value investor pickOptions Play & Consistent Profit Focused Trading Strategies - newser.com
Tivic Health Unveils Clinical Study Findings - TipRanks
Tivic Health Systems, Inc. Reports Clinical Optimization Study Findings - TradingView
Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS) - ACCESS Newswire
Tivic Health (NASDAQ: TIVC) reports personalized ncVNS 8.9x more effective for HRV - Stock Titan
Has Tivic Health Systems Inc. formed a bullish divergence2025 Historical Comparison & Free Growth Oriented Trading Recommendations - newser.com
Tivic Health optimizes nerve stimulation parameters in new study - Investing.com
Sentiment analysis tools applied to Tivic Health Systems Inc.2025 Market Sentiment & Expert Verified Movement Alerts - newser.com
Should you wait for a breakout in Tivic Health Systems Inc.Weekly Profit Report & Community Trade Idea Sharing - newser.com
Tivic Health files two new patents for cancer and bioelectronic therapies - Investing.com Australia
Tivic Health files two new patents for cancer and bioelectronic therapies By Investing.com - Investing.com South Africa
BellRing Brands (NYSE: BRBR) narrows outlook to $2.28–$2.32B; updates guidance - Stock Titan
Tivic Expands Intellectual Property Portfolio - The Joplin Globe
Tivic Health Systems Inc Stock (TIVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.89%
4.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):